FDA’s new plan to study opioids’ effectiveness faces resistance
A contentious hearing was the latest chapter in a long-running debate about the appropriate role of opioids in pain treatment, both for current patients and for future patients who wish…
The Food and Drug Administration’s latest plan to study whether opioids are effective as a chronic pain treatment is facing significant resistance from addiction and pain care experts.
A planned clinical trial, doctors and researchers argued on Wednesday, would not yield significant new information about whether opioids are effective as long-term treatments for chronic pain. The study, some charged, would be biased in favor of opioids’ efficacy — and by extension, biased in favor of painkiller manufacturers.
What's Your Reaction?
